Pure Global
PACTR201907764652028

Cardioprotective effect of propofol in cardioplegia compared to systemic propofol in heart valves surgery; a randomized controlled trial

Tanta University Hospital·Phase 4·Pan Africa Clinical Trials RegistryCompleted
Study focus
Disease/Condition
Surgery
Sponsor & location
Primary sponsor
Tanta University Hospital
Funder
self funding
Location
Egypt
Timeline & enrollment
Phase
Phase 4
Start date
Nov 11, 2018
End date
May 20, 2022
Summary

Cardiac surgery now is surrounded by alot of risk factors and the myocardial protection strategies is the way for the researchers to find out. Our goal is to detect the cardioprotective effect of the propofol whether in cardioplegia or systemically.

ICD-10 classifications
Other surgical proceduresSurgical procedure, unspecifiedDuring surgical operationDuring surgical operationDuring surgical operation
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201907764652028
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201907764652028 through Pure Global AI's free database. This Phase 4 trial is sponsored by Tanta University Hospital and is currently Completed. The study focuses on Surgery.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.